Published in Vaccine Weekly, October 22nd, 2008
More than 2.6 billion people are at risk of developing vivax malaria, with a heavy concentration of cases in Asia and Latin America. Although infection is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly